Translating skin and skin cancer research through clinical trials is critical in developing new methodologies of detection and diagnosis, effective treatments and patient support.
The ASSC, through the University of Queensland and QIMR Berghofer, has an effective research network for developing and supporting studies into advances in the prevention and early detection of skin cancer and the treatment of melanoma and skin diseases.
There are a number of studies and research papers underway, and these often require participants to assist.
ACRF Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) Cohort Study
Lead Investigator: Prof H Peter Soyer
ACRF ACEMID aims to develop more efficient and effective screening for the early detection of melanoma through the provision of an innovative 3D total body photography system.
Participants will be asked to participate in 3D total body photography every 6, 12 or 24 months for the 3 year study duration based on their melanoma risk. To be eligible to participate participants must be 18 years of age or older and have a regular medical practitioner.
There will be 15 ACEMID sites located in Queensland, New South Wales and Victoria.
For further information, contact firstname.lastname@example.org or visit acemid.org.au
Registration ID: ACTRN12619001706167
IMAGE: Melanoma Surveillance Photography to improve early detection of melanoma in very high risk (or high risk) patients
Lead Investigator: Associate Professor Victoria Mar
The IMAGE trial aims to assess whether using melanoma surveillance with baseline total body photography (with tagged dermoscopic images), results in improved diagnostic accuracy and earlier detection of melanoma compared to clinical surveillance without baseline photography as an aid. We also will investigate if using Melanoma Surveillance Photography significantly reduces the number of unnecessary biopsies in high risk individuals.
Study participants are randomised to either a control or intervention arm. Participants randomised to the intervention arm will attend a research clinic and receive baseline total body imaging with dermoscopy. These images will then be used as a baseline to compare future routine surveillance visits. Participant image files will be uploaded on to a secure USB, for participants to then review their images with their regular treating doctor or Dermatologist, where they will conduct a skin check using the images on file.
IMAGE study sites are located in Victoria, New South Wales and Queensland.
For further information, contact email@example.com.
Registration ID: NCT04385732
If you would like to participate in a clinical trial, please search the https://www.australianclinicaltrials.gov.au/ website for current and future trials.